News
- Author:
- Roxanne Nelson
Publish date: June 14, 2017
CHICAGO – Out-of-pocket costs may present a barrier to colorectal screening, and removing those costs could reduce colorectal cancer deaths, accord...
News
- Author:
- Roxanne Nelson
Publish date: June 12, 2017
Adenomas are too often missed, “partially because pathologists are not typically evaluating an entire specimen.”
News
- Author:
- Roxanne Nelson
Publish date: June 1, 2017
CHICAGO – Gluten-free may not be freeing for many recovering patients.
News
- Author:
- Roxanne Nelson
Publish date: June 1, 2017
CHICAGO – Would waiving out-of-pocket costs for colorectal cancer screening be cost effective?
News
- Author:
- Roxanne Nelson
Publish date: May 23, 2017
CHICAGO – Can use of biosimilars save money for IBD patients and health care systems?
News
- Author:
- Roxanne Nelson
Publish date: May 22, 2017
CHICAGO – Can serum cytokines after a gluten challenge diagnose celiac disease?
News
- Author:
- Roxanne Nelson
Publish date: May 10, 2017
Misoprostol was more effective than placebo in healing small bowel ulcers in patients who used daily low-dose aspirin.
News
- Author:
- Roxanne Nelson
Publish date: May 9, 2017
Careful screening of individuals with Lynch syndrome that includes removal of precancerous polyps may keep colorectal cancer rates down.
News
- Author:
- Roxanne Nelson
Publish date: May 8, 2017
CHICAGO – As compared to prolonged use of corticosteroids, the use of anti-TNF drugs was associated with reduced mortality in patients with Crohn’s...
News
- Author:
- Roxanne Nelson
Publish date: May 5, 2017
A total of eight patients achieved stable disease in the phase I study, including four with RCC.
News
- Author:
- Roxanne Nelson
Publish date: May 3, 2017
High CD86+pDC counts predicted relapses in chronic myeloid leukemia patients who stopped TKI therapy.
News
- Author:
- Roxanne Nelson
Publish date: April 17, 2017
SEATTLE – Delay between neoadjuvant therapy and surgery may offer some benefit to patients with pancreatic cancer.
News
- Author:
- Roxanne Nelson
Publish date: April 8, 2017
For breast cancer patients whose surgery is delayed, a course of neoadjuvant therapy may be beneficial, but the effectiveness depends on the durati...
News
- Author:
- Roxanne Nelson
Publish date: April 8, 2017
In a phase I trial, the immunotherapy agent atezolizumab improved survival in triple-negative breast cancer.
News
- Author:
- Roxanne Nelson
Publish date: April 6, 2017
“Avelumab could be an important new agent for patients with Merkel cell carcinoma who have failed prior chemotherapy,” said Dr. Howard L. Kaufman.<...
